Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Specific immunotherapy in asthma

J Bousquet1, F B Michel

  • 1University of Montpellier, France.

Allergy Proceedings : the Official Journal of Regional and State Allergy Societies
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Application of the WHO chronic respiratory diseases programme in Sub-Saharian Africa: problems in Senegal].

Revue des maladies respiratoires·2004
Same author

Specific immunotherapy in rhinitis and asthma.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2001
Same author

[From allergic rhinitis to sinus diseases (sinusitis/nasal polyps): epidemiologic and experimental links].

Revue des maladies respiratoires·2000
Same author

[Asthma and rhinitis medications: pregnancy precautions].

Presse medicale (Paris, France : 1983)·2000
Same author

[Corticosteroid therapy of asthma].

Presse medicale (Paris, France : 1983)·2000
Same author

[Drug allergies: a public health problem].

Bulletin de l'Academie nationale de medecine·2000
Same journal

William III (1650-1702) Prince of Orange and King of England, Scotland, and Ireland.

Allergy proceedings : the official journal of regional and state allergy societies·1995
Same journal

Sir John Floyer (1649-1734) British physician and pioneer clinical investigator.

Allergy proceedings : the official journal of regional and state allergy societies·1995
Same journal

Nicolas Boileaux-Despreaux (1636-1711) French poet, author, and literary critic.

Allergy proceedings : the official journal of regional and state allergy societies·1995
Same journal

John Locke (1632-1704) British physician and philosopher.

Allergy proceedings : the official journal of regional and state allergy societies·1995
Same journal

Chu I-Hai, Prince of Lu (1618-1662) last regent of the Chinese Ming dynasty.

Allergy proceedings : the official journal of regional and state allergy societies·1995
Same journal

Atopy and skin reactivity at school age in children followed up from birth, with special reference to atopy prevention in infancy and atopic findings at preschool age.

Allergy proceedings : the official journal of regional and state allergy societies·1995
See all related articles

Specific immunotherapy offers benefits for allergic asthma triggered by pollen, dust mites, animal dander, and molds. However, allergen avoidance remains the primary treatment due to potential systemic reactions.

Area of Science:

  • Allergy and Immunology
  • Respiratory Medicine
  • Immunotherapy

Background:

  • Asthma is increasingly recognized as an inflammatory condition.
  • Immunotherapy can modulate immune responses and inflammatory mediator production in asthma.

Purpose of the Study:

  • To review the role and effectiveness of specific immunotherapy in managing allergic asthma.
  • To highlight potential risks and benefits associated with different allergen immunotherapy approaches.

Main Methods:

  • Review of studies on specific immunotherapy for various allergens in asthma.
  • Analysis of patient populations (children vs. adults) and risk factors for systemic reactions.

Main Results:

  • Pollen immunotherapy (grass, birch, ragweed) shows benefits for pollen-sensitive asthma.

Related Experiment Videos

  • House dust mite immunotherapy is more effective in children than adults.
  • Animal dander and mold immunotherapy may benefit selected patients.
  • Systemic reaction risks are higher during allergen season and in patients with unstable pulmonary function.

    • Conclusions:

    • Specific immunotherapy can be beneficial for certain types of allergic asthma.
    • Allergen avoidance is currently the preferred treatment strategy.
    • Careful patient selection and administration timing are crucial to minimize risks.